MetaCap

Arq (ARQ) vs Codexis (CDXS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Arq (ARQ) has outperformed Codexis (CDXS) over the past year, losing 19.4% versus a loss of 34.4%. Over five years, ARQ leads with a -57.3% price change compared with -97.2% for CDXS. Arq is the larger company by market cap ($124.6 million vs $110.7 million), about 1.1 times the size, while Codexis is growing revenue faster (+18.6% vs +10.4%).

Arq converts more of its revenue into profit, with a net margin of -43.7% versus -62.5%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ARQ-19.43%CDXS-34.42%
+92%+16%-60%
Nov 21, 20251 yearNov 20, 2026
ARQ-59.54%CDXS-97.29%
+20%-41%-103%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ARQ versus CDXS key metrics
MetricARQCDXS
Share price$2.82$1.01
Market cap$124.61M$110.69M
1-day change-3.42%-3.81%
YTD return-13.76%-38.04%
1-year return-19.43%-34.42%
5-year return-57.34%-97.24%
Forward P/E188.00—
EPS (TTM)$-1.20$-0.18
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$120.34M$70.39M
Revenue growth (YoY)+10.44%+18.61%
Net income (latest FY)$-52.61M$-43.97M
Gross margin27.87%86.73%
Operating margin-44.01%-59.30%
Net margin-43.72%-62.47%
52-week high$4.02$2.98
52-week low$1.54$0.90
Distance from 52-week high-29.85%-66.11%
Analyst consensusstrong_buybuy
Avg. price target upside+50.71%+507.92%
Average volume494.33K918.15K
Shares outstanding44.19M109.60M
Employees201146
SectorIndustrialsIndustrials
IndustryMajor ChemicalsMajor Chemicals

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ARQ has outperformed CDXS by 15.0 percentage points over the past year.
  • Arq is more profitable, keeping -43.7 cents of every revenue dollar as net income versus -62.5 cents for Codexis.
  • Codexis grew revenue faster in its latest fiscal year (+18.61% vs +10.44%).

About Arq

ARQ stock →

Arq, Inc., an environmental technology company, engages in the sale of consumable air, water, and soil treatment solutions based on activated carbon in the United States and Canada. Its products include granular activated carbon, powdered activated carbon, and colloidal carbon products; and additives for air emissions control.

Industrials · Major Chemicals · 201 employees

About Codexis

CDXS stock →

Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China.

Industrials · Major Chemicals · 146 employees

ARQ vs CDXS FAQ

Which is bigger, Arq or Codexis?

Arq (ARQ) is larger, with a market capitalization of $124.61M compared with $110.69M for Codexis (CDXS).

Which stock has performed better over the past year, ARQ or CDXS?

ARQ returned -19.43% over the past 12 months, compared with -34.42% for CDXS (price return, excluding dividends). Past performance does not predict future results.

Are Arq and Codexis in the same industry?

Yes. Both are classified in the Major Chemicals industry within the Industrials sector.

More comparisons